Cargando…
The Predictive and Prognostic Nature of Programmed Death-Ligand 1 in Malignant Pleural Mesothelioma: A Systematic Literature Review
INTRODUCTION: Given the emergence of combination of programmed cell death protein-1 and CTLA4 pathway blockade as effective treatment options in malignant pleural mesothelioma (MPM), there is interest in the extent to which programmed death-ligand 1 (PD-L1) expression may be prognostic of clinical o...
Autores principales: | Mansfield, Aaron S., Brown, Rebecca J., Sammon, Cormac, Daumont, Melinda J., McKenna, Mike, Sanzari, Jenine K., Forde, Patrick M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062484/ https://www.ncbi.nlm.nih.gov/pubmed/35516726 http://dx.doi.org/10.1016/j.jtocrr.2022.100315 |
Ejemplares similares
-
Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe
por: Moore, Adam, et al.
Publicado: (2022) -
Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience?
por: Moore, Adam, et al.
Publicado: (2023) -
Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results‐Medicare data
por: Danese, Mark D., et al.
Publicado: (2021) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)